These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16564172)

  • 1. Type III secretion gets an LcrV tip.
    Mota LJ
    Trends Microbiol; 2006 May; 14(5):197-200. PubMed ID: 16564172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles.
    Mueller CA; Broz P; Müller SA; Ringler P; Erne-Brand F; Sorg I; Kuhn M; Engel A; Cornelis GR
    Science; 2005 Oct; 310(5748):674-6. PubMed ID: 16254184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The type III secretion system tip complex and translocon.
    Mueller CA; Broz P; Cornelis GR
    Mol Microbiol; 2008 Jun; 68(5):1085-95. PubMed ID: 18430138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of the formation of the Ysc-Yop translocation pore in macrophages by Yersinia enterocolitica: role of LcrV, YscF and YopN.
    Marenne MN; Journet L; Mota LJ; Cornelis GR
    Microb Pathog; 2003 Dec; 35(6):243-58. PubMed ID: 14580388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function and molecular architecture of the Yersinia injectisome tip complex.
    Broz P; Mueller CA; Müller SA; Philippsen A; Sorg I; Engel A; Cornelis GR
    Mol Microbiol; 2007 Sep; 65(5):1311-20. PubMed ID: 17697254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LcrV mutants that abolish Yersinia type III injectisome function.
    Ligtenberg KG; Miller NC; Mitchell A; Plano GV; Schneewind O
    J Bacteriol; 2013 Feb; 195(4):777-87. PubMed ID: 23222719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YscU recognizes translocators as export substrates of the Yersinia injectisome.
    Sorg I; Wagner S; Amstutz M; Müller SA; Broz P; Lussi Y; Engel A; Cornelis GR
    EMBO J; 2007 Jun; 26(12):3015-24. PubMed ID: 17510628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yersinia enterocolitica type III secretion chaperone SycD: recombinant expression, purification and characterization of a homodimer.
    Schmid A; Dittmann S; Grimminger V; Walter S; Heesemann J; Wilharm G
    Protein Expr Purif; 2006 Oct; 49(2):176-82. PubMed ID: 16750393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of LcrG and LcrV during type III targeting of effector Yops by Yersinia enterocolitica.
    DeBord KL; Lee VT; Schneewind O
    J Bacteriol; 2001 Aug; 183(15):4588-98. PubMed ID: 11443094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH sensitivity of type III secretion system tip proteins.
    Markham AP; Birket SE; Picking WD; Picking WL; Middaugh CR
    Proteins; 2008 Jun; 71(4):1830-42. PubMed ID: 18175320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tranquilizing injection of Yersinia proteins: a pathogen's strategy to resist host defense.
    Aepfelbacher M; Zumbihl R; Ruckdeschel K; Jacobi CA; Barz C; Heesemann J
    Biol Chem; 1999; 380(7-8):795-802. PubMed ID: 10494828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effector functions of pathogenic Yersinia species.
    Aepfelbacher M; Trasak C; Ruckdeschel K
    Thromb Haemost; 2007 Sep; 98(3):521-9. PubMed ID: 17849040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type III secretion: the bacteria-eukaryotic cell express.
    Mota LJ; Sorg I; Cornelis GR
    FEMS Microbiol Lett; 2005 Nov; 252(1):1-10. PubMed ID: 16216444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type III secretion: a bacterial device for close combat with cells of their eukaryotic host.
    Cornelis GR
    Philos Trans R Soc Lond B Biol Sci; 2000 May; 355(1397):681-93. PubMed ID: 10874740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attachment of LcrV from Yersinia pestis at dual binding sites to human TLR-2 and human IFN-gamma receptor.
    Abramov VM; Khlebnikov VS; Vasiliev AM; Kosarev IV; Vasilenko RN; Kulikova NL; Khodyakova AV; Evstigneev VI; Uversky VN; Motin VL; Smirnov GB; Brubaker RR
    J Proteome Res; 2007 Jun; 6(6):2222-31. PubMed ID: 17441749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes.
    Goure J; Broz P; Attree O; Cornelis GR; Attree I
    J Infect Dis; 2005 Jul; 192(2):218-25. PubMed ID: 15962216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. V-antigen homologs in pathogenic gram-negative bacteria.
    Sawa T; Katoh H; Yasumoto H
    Microbiol Immunol; 2014 May; 58(5):267-85. PubMed ID: 24641673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the Yersinia type III secretion system: traffic control.
    Dewoody RS; Merritt PM; Marketon MM
    Front Cell Infect Microbiol; 2013; 3():4. PubMed ID: 23390616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LcrG-LcrV interaction is required for control of Yops secretion in Yersinia pestis.
    Matson JS; Nilles ML
    J Bacteriol; 2001 Sep; 183(17):5082-91. PubMed ID: 11489861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Yersinia Ysc-Yop 'type III' weaponry.
    Cornelis GR
    Nat Rev Mol Cell Biol; 2002 Oct; 3(10):742-52. PubMed ID: 12360191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.